...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Effects of GABA(B) receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination.
【24h】

Effects of GABA(B) receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination.

机译:GABA(B)受体拮抗剂,激动剂和变构正调节剂对可卡因诱导的自我给药和药物歧视的影响。

获取原文
获取原文并翻译 | 示例

摘要

Preclinical and clinical findings indicate that a GABA(B) receptor agonist baclofen decreases cocaine use. The present study investigated the effects of the GABA(B) receptor antagonist (2S)-(+)-5,5-dimethyl-2-morpholineacetic acid (SCH 50911), the agonists baclofen and 3-aminopropyl(methyl)phoshinic acid (SKF 97541) and the allosteric positive modulator 3,5-bis(1,1-dimethylethyl-4-hydroxy-beta,beta-dimethylbenzenepropanol (CGP 7930) in cocaine-and food-maintained responding under a fixed ratio 5 schedule of reinforcement in male Wistar rats. The effects of the GABA(B) receptor ligands on cocaine (10 mg/kg)-induced discriminative stimulus in a two-lever, water-reinforced fixed ratio 20 task and on basal locomotor activity were also assessed. Baclofen (2.5-5 mg/kg), SKF 97541 (0.1-0.3 mg/kg) and CGP 7930 (30-100 mg/kg) decreased the cocaine (0.5 mg/kg/injection)-maintained responding; SCH 50911 (3-10 mg/kg) was inactive in this respect. Baclofen (5 mg/kg) and SKF 97541 (0.3 mg/kg), but not CGP 7930 or SCH 50911 attenuated the food-maintained responding. The inhibitory effects of the GABA(B) receptor agonists and the modulator were blocked by SCH 50911. SKF 97541 (0.1 mg/kg) or CGP 9730 (30-100 mg/kg) did not produce a significant shift in the cocaine (1.25-10 mg/kg) dose-response curve in a drug discrimination procedure, while baclofen (1.5 mg/kg) or SCH 50911 (10 mg/kg) attenuated the effects of separate doses of cocaine. Baclofen (5 mg/kg) and CGP 7930 (100 mg/kg) significantly reduced basal horizontal activity. We found that pharmacological stimulation of GABA(B) receptors by direct agonists or allosteric positive modulation reduces cocaine reinforcement while this property of cocaine is not related to tonic activation of GABA(B) receptors. The GABA(B) receptor stimulation-induced reduction of cocaine reinforcement was separated from its discriminative stimulus effects. Moreover, a dissociation between effects of direct GABA(B) receptor agonists and a GABA(B) allosteric positive modulator on cocaine vs.food-maintained responding was demonstrated.
机译:临床前和临床发现表明,GABA(B)受体激动剂巴氯芬减少了可卡因的使用。本研究调查了GABA(B)受体拮抗剂(2S)-(+)-5,5-二甲基-2-吗啉乙酸(SCH 50911),激动剂巴氯芬和3-氨丙基(甲基)次膦酸(可卡因和食物维持的变构正调节剂3,5-双(1,1-二甲基乙基-4-羟基-β,β-二甲基苯丙醇(CGP 7930))在固定比例下5的强化时间表雄性Wistar大鼠。还评估了GABA(B)受体配体对可卡因(10 mg / kg)所致的两杆水强化固定比例20任务的歧视性刺激以及对基础运动活性的影响。 2.5-5 mg / kg),SKF 97541(0.1-0.3 mg / kg)和CGP 7930(30-100 mg / kg)降低了可卡因(0.5 mg / kg /注射)维持的响应; SCH 50911(3-10在这方面没有活性。巴氯芬(5 mg / kg)和SKF 97541(0.3 mg / kg),但没有CGP 7930或SCH 50911减弱了食物维持的响应。GABA(B)的抑制作用[R受体激动剂和调节剂被SCH 50911阻断。SKF97541(0.1 mg / kg)或CGP 9730(30-100 mg / kg)在可卡因(1.25-10 mg / kg)剂量反应中未产生明显变化药物歧视程序中的曲线变化,而巴氯芬(1.5 mg / kg)或SCH 50911(10 mg / kg)减弱了不同剂量可卡因的作用。 Baclofen(5 mg / kg)和CGP 7930(100 mg / kg)显着降低了基础水平活动。我们发现,通过直接激动剂或变构正调制对GABA(B)受体进行药理学刺激会降低可卡因的强化作用,而可卡因的这一特性与GABA(B)受体的补品激活无关。 GABA(B)受体刺激诱导的可卡因强化减少与它的歧视性刺激作用是分开的。此外,在可卡因与食物维持反应之间,直接GABA(B)受体激动剂和GABA(B)变构阳性调节剂之间的作用被证明是分离的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号